Skip to main content
. Author manuscript; available in PMC: 2014 Mar 4.
Published in final edited form as: Am J Prev Med. 2009 Jan;36(1):13–20. doi: 10.1016/j.amepre.2008.09.030

Table 3.

Annual avoidable burden of CHD due to passive smoking, 2008-2037

Status quo 2001 Trend case 2008
Exposure criterion: serum cotinine (ng/mL) ≥0.05 ≥0.10 ≥0.05 ≥0.10
RR of CHD due to passive smoking: 1.26
Deaths
    M 27,700 17,700 20,900 11,900
    SE 800 700 800 600
Total MIs
    M 48,400 31,400 36,500 21,500
    SE 1,400 1,200 1,300 1,100
First MIs
    M 27,600 18,000 20,900 12,300
    SE 800 700 800 700
Total CHD events
    M 58,400 37,800 44,100 25,900
    SE 1,700 1,500 1,600 1,000
CHD treatment cost (million $ 2000 )
    Mean 2,300 1,500 1,700 1,000
    SE 100 100 100 100
RR of CHD due to passive smoking: 1.65
Deaths
    M 59,300 38,100 44,600 25,800
    SE 1,800 1,500 1,700 1,400
Total MIs
    M 105,100 69,100 79,300 46,300
    SE 3,400 2,800 3,000 2,500
First MIs
    M 61,800 40,700 46,700 27,300
    SE 2,000 1,600 1,800 1,500
Total CHD events
    M 126,000 82,100 95,000 55,100
    SE 4,000 3,300 3,600 2,900
CHD treatment cost (million $2000)
    M 5,000 3,300 3,700 2,200
    SE 200 100 100 100

CHD, coronary heart disease; MI, myocardial infarction; ng/mL, nanograms/milliliter; RR, relative risk